|
US6060592A
(en)
|
1990-01-11 |
2000-05-09 |
Isis Pharmaceuticals, Inc. |
Pyrimidine nucleoside compounds and oligonucleoside compounds containing same
|
|
US5798340A
(en)
|
1993-09-17 |
1998-08-25 |
Gilead Sciences, Inc. |
Nucleotide analogs
|
|
JPH09328497A
(ja)
|
1996-04-12 |
1997-12-22 |
Yamasa Shoyu Co Ltd |
４’−フルオロメチルヌクレオシド
|
|
ATE250622T1
(de)
|
1999-05-12 |
2003-10-15 |
Yamasa Corp |
4'-c-ethynyl-pyrimidine nukleoside
|
|
EP2180064A3
(en)
|
2000-10-18 |
2010-08-11 |
Pharmasset, Inc. |
Multiplex quantification of nucleic acids in diseased cells
|
|
WO2002062197A2
(en)
|
2000-12-19 |
2002-08-15 |
Hospital For Special Surgery |
Markers for disease susceptibility and targets for therapy
|
|
US7105499B2
(en)
|
2001-01-22 |
2006-09-12 |
Merck & Co., Inc. |
Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
|
|
GB0114286D0
(en)
|
2001-06-12 |
2001-08-01 |
Hoffmann La Roche |
Nucleoside Derivatives
|
|
AU2003220277A1
(en)
|
2002-03-12 |
2003-09-29 |
The Johns Hopkins University School Of Medicine |
Manganese ion regulation of reverse transcriptase activity and methods of modulating same
|
|
WO2004000858A2
(en)
|
2002-06-21 |
2003-12-31 |
Merck & Co., Inc. |
Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
|
|
US20050113324A1
(en)
|
2003-01-15 |
2005-05-26 |
Bondarev Igor E. |
Modulation of line-1 reverse transcriptase
|
|
HUE029877T2
(en)
|
2003-05-30 |
2017-04-28 |
Gilead Pharmasset Llc |
Modified fluorinated nucleoside analogues
|
|
US20070281911A1
(en)
|
2004-01-21 |
2007-12-06 |
Gilead Sciences Inc. |
Use of Adefovir or Tenofovir for Inhibiting Mmtv-Like Viruses Involved in Breast Cancer and Primary Biliary Cirrhosis
|
|
CA2502109C
(en)
|
2004-03-24 |
2010-02-23 |
Yamasa Corporation |
4'-c-substituted-2-haloadenosine derivative
|
|
WO2008030605A2
(en)
|
2006-09-08 |
2008-03-13 |
The Regents Of The University Of Michigan |
Herv group ii viruses in lymphoma and cancer
|
|
US7964580B2
(en)
|
2007-03-30 |
2011-06-21 |
Pharmasset, Inc. |
Nucleoside phosphoramidate prodrugs
|
|
EP1980568A1
(de)
|
2007-04-13 |
2008-10-15 |
Eberhard Karls Universität Tübingen |
Ethinylierte Heterodinucleosidphosphatanaloga, Verfahren zu deren Herstellung und deren Verwendung
|
|
CN100532388C
(zh)
*
|
2007-07-16 |
2009-08-26 |
郑州大学 |
2’-氟-4’-取代-核苷类似物、其制备方法及应用
|
|
US20090318380A1
(en)
|
2007-11-20 |
2009-12-24 |
Pharmasset, Inc. |
2',4'-substituted nucleosides as antiviral agents
|
|
US8173621B2
(en)
|
2008-06-11 |
2012-05-08 |
Gilead Pharmasset Llc |
Nucleoside cyclicphosphates
|
|
US8163707B2
(en)
*
|
2008-09-15 |
2012-04-24 |
Enanta Pharmaceuticals, Inc. |
4′-allene-substituted nucleoside derivatives
|
|
BRPI1010809A2
(pt)
*
|
2009-05-12 |
2015-10-13 |
Southern Res Inst |
composto, composição farmacêutica, métodos de tratar câncer em mamífero e usos de compostos e de composição farmacêutica
|
|
WO2010135690A1
(en)
|
2009-05-21 |
2010-11-25 |
The Regents Of The University Of Michigan |
Antiviral treatment of lymphoma and cancer
|
|
AR083221A1
(es)
|
2010-09-29 |
2013-02-06 |
Univ Nac Quilmes |
Proceso para producir dialquilfosfotriesteres de nucleosidos mediante transesterificacion enzimatica y desproteccion de los mismos para producir nucleosidos monofosfato
|
|
EP2625292B1
(en)
|
2010-10-07 |
2018-12-05 |
The General Hospital Corporation |
Biomarkers of cancer
|
|
DK2658399T4
(da)
|
2010-12-31 |
2024-03-25 |
Abbott Lab |
Ernæringssammensætninger omfattende humane mælkeoligosaccharider til anvendelse i behandling og/eller forebyggelse af enterisk rotavirus-infektion
|
|
US8877733B2
(en)
|
2011-04-13 |
2014-11-04 |
Gilead Sciences, Inc. |
1′-substituted pyrimidine N-nucleoside analogs for antiviral treatment
|
|
US20120321637A1
(en)
|
2011-06-20 |
2012-12-20 |
The Board Of Regents Of The University Of Texas System |
Combination cancer therapy with herv inhibition
|
|
SG10201913554YA
(en)
|
2011-12-22 |
2020-03-30 |
Alios Biopharma Inc |
Substituted nucleosides, nucleotides and analogs thereof
|
|
GEP201706721B
(en)
*
|
2012-03-21 |
2017-08-25 |
Alios Biopharma Inc |
Substituted nucleosides, nucleotides and analogs thereof
|
|
US9441007B2
(en)
|
2012-03-21 |
2016-09-13 |
Alios Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
|
WO2014047117A1
(en)
|
2012-09-18 |
2014-03-27 |
Bristol-Myers Squibb Company |
Process for preparing phosphoramidate derivatives of nucleoside compounds for treatment of viral infections
|
|
HK1214270A1
(zh)
|
2012-10-29 |
2016-07-22 |
共晶制药股份有限公司 |
用於治療病毒感染和癌症的嘧啶核苷及其單磷酸酯前藥
|
|
EP2971120B1
(en)
|
2013-03-15 |
2018-06-06 |
Cold Spring Harbor Laboratory |
Transposon activation during aging and neuronal decline
|
|
AU2014302711A1
(en)
|
2013-06-26 |
2015-12-10 |
Alios Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
|
LT3043803T
(lt)
|
2013-09-11 |
2022-08-10 |
Emory University |
Nukleotidų ir nukleozidų kompozicijos ir jų panaudojimas
|
|
WO2015054465A1
(en)
|
2013-10-11 |
2015-04-16 |
Alios Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
|
EA033866B1
(ru)
*
|
2014-02-06 |
2019-12-03 |
Рибосайенс Ллк |
4'-дифторметилзамещенные производные нуклеозидов в качестве ингибиторов репликации рнк вируса гриппа
|
|
WO2015143712A1
(en)
|
2014-03-28 |
2015-10-01 |
Merck Sharp & Dohme Corp. |
4'-substituted nucleoside reverse transcriptase inhibitors
|
|
EP3137124B1
(en)
|
2014-04-29 |
2019-01-09 |
Microvention, Inc. |
Polymers including active agents
|
|
US20170100385A1
(en)
|
2014-05-12 |
2017-04-13 |
Glaxosmithkline Intellectual Property (No. 2) Limited |
Pharmaceutical compositions comprising danirixin for treating infectious diseases
|
|
HUE051986T2
(hu)
|
2014-06-24 |
2021-04-28 |
Janssen Biopharma Inc |
Helyettesített nukleozidok, nukleotidek és analógjaik virális fertõzés kezelésére való alkalmazásra
|
|
MA40031A
(fr)
|
2014-06-24 |
2015-12-30 |
Alios Biopharma Inc |
Nucléosides substitués, nucléotides et analogues de ceux-ci
|
|
EP3161159B1
(en)
|
2014-06-25 |
2020-08-05 |
The General Hospital Corporation |
Targeting human satellite ii (hsatii)
|
|
CA2955604A1
(en)
|
2014-07-22 |
2016-01-28 |
Alios Biopharma, Inc. |
Methods for treating paramyxoviruses
|
|
PE20170673A1
(es)
|
2014-08-05 |
2017-05-22 |
Alios Biopharma Inc |
Terapia de combinacion para tratar una paramixovirus
|
|
TWI673283B
(zh)
|
2014-08-21 |
2019-10-01 |
美商基利科學股份有限公司 |
２’－氯胺基嘧啶酮及嘧啶二酮核苷類
|
|
AU2015320511B2
(en)
|
2014-09-26 |
2020-11-12 |
Riboscience Llc |
4'-vinyl substituted nucleoside derivatives as inhibitors of Respiratory Syncytial Virus RNA replication
|
|
WO2016069489A1
(en)
|
2014-10-28 |
2016-05-06 |
Alios Biopharma, Inc. |
Methods of preparing substituted nucleoside analogs
|
|
FR3027804A1
(fr)
|
2014-10-31 |
2016-05-06 |
Centre Nat Rech Scient |
Utilisation d'un inhibiteur de transcriptase inverse dans la prevention et le traitement des maladies degeneratives
|
|
MA41213A
(fr)
|
2014-12-19 |
2017-10-24 |
Alios Biopharma Inc |
Nucléosides substitués, nucléotides et analogues de ceux-ci
|
|
JP7381190B2
(ja)
|
2014-12-26 |
2023-11-15 |
エモリー・ユニバーシテイ |
Ｎ４－ヒドロキシシチジン及び誘導体並びにそれに関連する抗ウイルス用途
|
|
WO2016138425A1
(en)
|
2015-02-26 |
2016-09-01 |
University Of Kentucky Research Foundation |
Compositions and methods for treating retinal degradation
|
|
WO2016145142A1
(en)
|
2015-03-10 |
2016-09-15 |
Emory University |
Nucleotide and nucleoside therapeutics compositions and uses related thereto
|
|
WO2016149366A1
(en)
|
2015-03-16 |
2016-09-22 |
The Johns Hopkins University |
Methods and compositions for treating cancer
|
|
EP3317290A4
(en)
|
2015-07-02 |
2019-04-10 |
Spring Bank Pharmaceuticals, Inc. |
COMPOSITIONS AND METHOD FOR TREATING VIRUS INFECTION
|
|
JP6767011B2
(ja)
|
2015-09-18 |
2020-10-14 |
ヤマサ醤油株式会社 |
抗ｄｎａウィルス活性などの生理活性を有するヌクレオシド誘導体
|
|
EP3355924A1
(en)
|
2015-09-29 |
2018-08-08 |
The U.S.A. as represented by the Secretary, Department of Health and Human Services |
Methods of treating and preventing amyotrophic lateral sclerosis
|
|
WO2017142984A1
(en)
|
2016-02-16 |
2017-08-24 |
Riboscience Llc |
Inhibitors of zika virus
|
|
US10874683B2
(en)
|
2016-03-10 |
2020-12-29 |
Emory University |
N4-hydroxycytidine and derivatives and anti-viral uses related thereto
|
|
WO2017222911A1
(en)
|
2016-06-20 |
2017-12-28 |
The Board Of Trustees Of The Leland Stanford Junior University |
Circular rnas and their use in immunomodulation
|
|
US20180117042A1
(en)
|
2016-10-27 |
2018-05-03 |
Alios Biopharma, Inc. |
Methods for treating respiratory syncytial virus infection
|
|
WO2018093777A1
(en)
|
2016-11-15 |
2018-05-24 |
The Regents Of The University Of Michigan |
Centromere analysis
|
|
AU2018210001A1
(en)
|
2017-01-23 |
2019-08-01 |
Health Research, Inc. |
Inhibition of endogenous reverse transcriptase and targeting of cells for prophylaxis and therapy of cancer and aging
|
|
WO2018208727A1
(en)
|
2017-05-08 |
2018-11-15 |
Eternity Bioscience Inc. |
Nucleoside and nucleotide analogues as cd73 inhibitors and therapeutic uses thereof
|
|
WO2018222774A1
(en)
|
2017-05-30 |
2018-12-06 |
Alios Biopharma, Inc. |
Methods for treating pneumoviruses
|
|
CN111971284A
(zh)
|
2017-12-27 |
2020-11-20 |
埃默里大学 |
核苷和/或nadph氧化酶(nox)抑制剂作为髓样特异性抗病毒剂的联合模式
|
|
EP4317972A3
(en)
|
2018-02-06 |
2024-03-13 |
The General Hospital Corporation |
Repeat rna as biomarkers of tumor immune response
|
|
WO2019246376A1
(en)
|
2018-06-20 |
2019-12-26 |
Chernova Olga B |
Prevention of primary and treatment-resistant cancer by inhibitors of endogenous reverse transcriptase
|
|
US20220110963A1
(en)
|
2019-01-02 |
2022-04-14 |
The General Hospital Corporation |
Reverse transcriptase blocking agents and methods of using the same
|
|
EP3914604B1
(en)
|
2019-01-25 |
2026-03-04 |
Brown University |
Compositions comprising censavudine or elvucitabine for treating age-associated inflammation and disorders
|
|
JP2023512656A
(ja)
|
2020-01-27 |
2023-03-28 |
ギリアード サイエンシーズ， インコーポレイテッド |
ＳＡＲＳ ＣｏＶ－２感染を治療するための方法
|
|
CN113304166B
(zh)
|
2020-02-27 |
2022-10-14 |
河南真实生物科技有限公司 |
核苷类化合物在制备治疗冠状病毒感染性疾病的药物中的用途
|
|
EP4114409A4
(en)
|
2020-03-20 |
2024-08-07 |
University of Virginia Patent Foundation |
NRTIS, NRTI METABOLITES AND NRTI ANALOGUES FOR MACULAR DEGENERATION AND VIRAL INFECTIONS
|
|
TW202228724A
(zh)
|
2020-09-23 |
2022-08-01 |
美商昂克萊亞製藥公司 |
以反轉錄酶抑制劑治療癌症之方法
|
|
KR20230107543A
(ko)
*
|
2020-09-23 |
2023-07-17 |
트랜스포손 테라퓨틱스, 인코포레이티드 |
질병을 치료하기 위한 line-1 억제제
|
|
KR20230157430A
(ko)
|
2021-03-15 |
2023-11-16 |
트랜스포손 테라퓨틱스, 인코포레이티드 |
Cns 및 전신 질병을 치료하기 위한 line-1 억제제
|
|
MX2023011870A
(es)
|
2021-04-09 |
2023-12-07 |
Univ Emory |
Análogos de nucleósidos y de nucleótidos como agentes antivirales para coronavirus y otros virus.
|
|
US20240261317A1
(en)
|
2021-05-17 |
2024-08-08 |
Rome Therapeutics, Inc. |
Methods of treating medical conditions and inhibiting line1 reverse transcriptaseusing a substituted 4-fluoro-2,5-dihydrofuranyl phosphonic acid or related compound
|
|
CN114288313B
(zh)
|
2022-02-18 |
2023-07-04 |
常晓宇 |
嘧啶核苷类药物在制备预防或治疗冠状病毒感染性疾病药物中的用途
|